These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 33741394)

  • 1. Sildenafil prevents HDACi-induced Epstein-Barr virus reactivation through the PKG pathway in NK/T cell lymphoma; potential implications for HDACi-mediated fatal complications.
    Kim JH; Kim WS; Park C
    Antiviral Res; 2021 May; 189():105063. PubMed ID: 33741394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus reactivation in extranodal natural killer/T-cell lymphoma patients: a previously unrecognized serious adverse event in a pilot study with romidepsin.
    Kim SJ; Kim JH; Ki CS; Ko YH; Kim JS; Kim WS
    Ann Oncol; 2016 Mar; 27(3):508-13. PubMed ID: 26658891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.
    Ye J; Gradoville L; Daigle D; Miller G
    J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase inhibitor romidepsin induces efficient tumor cell lysis via selective down-regulation of LMP1 and c-myc expression in EBV-positive diffuse large B-cell lymphoma.
    Shin DY; Kim A; Kang HJ; Park S; Kim DW; Lee SS
    Cancer Lett; 2015 Aug; 364(2):89-97. PubMed ID: 25790907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Epstein-Barr virus reactivation in nasopharyngeal carcinoma cells by dietary sulforaphane.
    Wu CC; Chuang HY; Lin CY; Chen YJ; Tsai WH; Fang CY; Huang SY; Chuang FY; Lin SF; Chang Y; Chen JY
    Mol Carcinog; 2013 Dec; 52(12):946-58. PubMed ID: 22641235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valpromide Inhibits Lytic Cycle Reactivation of Epstein-Barr Virus.
    Gorres KL; Daigle D; Mohanram S; McInerney GE; Lyons DE; Miller G
    mBio; 2016 Mar; 7(2):e00113. PubMed ID: 26933051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Epstein-Barr Virus Lytic Reactivation by the Atypical Antipsychotic Drug Clozapine.
    Anderson AG; Gaffy CB; Weseli JR; Gorres KL
    Viruses; 2019 May; 11(5):. PubMed ID: 31108875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir.
    Hui KF; Cheung AK; Choi CK; Yeung PL; Middeldorp JM; Lung ML; Tsao SW; Chiang AK
    Int J Cancer; 2016 Jan; 138(1):125-36. PubMed ID: 26205347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1.
    Jung YJ; Choi H; Kim H; Lee SK
    J Virol; 2014 Aug; 88(16):9027-37. PubMed ID: 24899173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interplay between PKCδ and Sp1 on histone deacetylase inhibitor-mediated Epstein-Barr virus reactivation.
    Tsai PF; Lin SJ; Weng PL; Tsai SC; Lin JH; Chou YC; Tsai CH
    J Virol; 2011 Mar; 85(5):2373-85. PubMed ID: 21159880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivation of Epstein-Barr Virus by HIF-1α Requires p53.
    Kraus RJ; Cordes BA; Sathiamoorthi S; Patel P; Yuan X; Iempridee T; Yu X; Lee DL; Lambert PF; Mertz JE
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular immediate-early gene expression occurs kinetically upstream of Epstein-Barr virus bzlf1 and brlf1 following cross-linking of the B cell antigen receptor in the Akata Burkitt lymphoma cell line.
    Ye J; Gradoville L; Miller G
    J Virol; 2010 Dec; 84(23):12405-18. PubMed ID: 20861250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral genome methylation differentially affects the ability of BZLF1 versus BRLF1 to activate Epstein-Barr virus lytic gene expression and viral replication.
    Wille CK; Nawandar DM; Panfil AR; Ko MM; Hagemeier SR; Kenney SC
    J Virol; 2013 Jan; 87(2):935-50. PubMed ID: 23135711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulus duration and response time independently influence the kinetics of lytic cycle reactivation of Epstein-Barr virus.
    Countryman J; Gradoville L; Bhaduri-McIntosh S; Ye J; Heston L; Himmelfarb S; Shedd D; Miller G
    J Virol; 2009 Oct; 83(20):10694-709. PubMed ID: 19656890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential role of PKCdelta in histone deacetylase inhibitor-induced Epstein-Barr virus reactivation in nasopharyngeal carcinoma cells.
    Lee HH; Chang SS; Lin SJ; Chua HH; Tsai TJ; Tsai K; Lo YC; Chen HC; Tsai CH
    J Gen Virol; 2008 Apr; 89(Pt 4):878-883. PubMed ID: 18343827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The heat-shock protein 90 inhibitor, geldanamycin, induces apoptotic cell death in Epstein-Barr virus-positive NK/T-cell lymphoma by Akt down-regulation.
    Jeon YK; Park CH; Kim KY; Li YC; Kim J; Kim YA; Paik JH; Park BK; Kim CW; Kim YN
    J Pathol; 2007 Oct; 213(2):170-9. PubMed ID: 17768706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation profiling of Epstein-Barr virus immediate-early gene promoters, BZLF1 and BRLF1 in tumors of epithelial, NK- and B-cell origins.
    Li L; Su X; Choi GC; Cao Y; Ambinder RF; Tao Q
    BMC Cancer; 2012 Mar; 12():125. PubMed ID: 22458933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-inducible factor-1α plays roles in Epstein-Barr virus's natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF1 gene promoter.
    Kraus RJ; Yu X; Cordes BA; Sathiamoorthi S; Iempridee T; Nawandar DM; Ma S; Romero-Masters JC; McChesney KG; Lin Z; Makielski KR; Lee DL; Lambert PF; Johannsen EC; Kenney SC; Mertz JE
    PLoS Pathog; 2017 Jun; 13(6):e1006404. PubMed ID: 28617871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA Damage Signaling Is Induced in the Absence of Epstein-Barr Virus (EBV) Lytic DNA Replication and in Response to Expression of ZEBRA.
    Wang'ondu R; Teal S; Park R; Heston L; Delecluse H; Miller G
    PLoS One; 2015; 10(5):e0126088. PubMed ID: 25950714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin.
    Hsu CH; Hergenhahn M; Chuang SE; Yeh PY; Wu TC; Gao M; Cheng AL
    Anticancer Res; 2002; 22(6C):4065-71. PubMed ID: 12553034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.